Catheter Precision (FRA:4RM) LT-Debt-to-Total-Asset: 0.11 (As of Mar. 2026)

What is Catheter Precision LT-Debt-to-Total-Asset?

Catheter Precision FRA:4RM 23 LT-Debt-to-Total-Asset is 0.11 as of Mar. 2026. GuruFocus rates FRA:4RM with a GF Score™ of 23/100 and a GF Value™ of €218.38. The stock has 7 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Catheter Precision's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.11.

Catheter Precision's long-term debt to total assets ratio increased from Mar. 2025 (0.00) to Mar. 2026 (0.11). It may suggest that Catheter Precision is progressively becoming more dependent on debt to grow their business.

Catheter Precision (FRA:4RM) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Catheter Precision LT-Debt-to-Total-Asset Related Terms

Catheter Precision LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Catheter Precision's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Catheter Precision LT-Debt-to-Total-Asset Chart

Catheter Precision Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.09

0.00

0.06

0.20

Catheter Precision Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.05	0.06	0.20	0.11

23GF Score

Catheter Precision Inc FRA:4RM

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Catheter Precision LT-Debt-to-Total-Asset Calculation

Catheter Precision's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	2.715	/	13.544
	=	0.20

Catheter Precision's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	3.413	/	30.349
	=	0.11

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.11 mean?

Catheter Precision (FRA:4RM) has a LT-Debt-to-Total-Asset of 0.11 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Catheter Precision and its competitors.

Is Catheter Precision's LT-Debt-to-Total-Asset too high?

Catheter Precision's current LT-Debt-to-Total-Asset is 0.11. Overall, Catheter Precision has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.

How does Catheter Precision's LT-Debt-to-Total-Asset compare to ALURD and BJDX?

Catheter Precision's LT-Debt-to-Total-Asset of 0.11 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Catheter Precision and its competitors. Catheter Precision's current LT-Debt-to-Total-Asset is 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Catheter Precision stock overvalued right now?

Catheter Precision (FRA:4RM) has a current LT-Debt-to-Total-Asset of 0.11. The stock's GF Value™ is €218.38, compared to a current price of €100.89 — trading 53.8% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.11. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Catheter Precision (FRA:4RM), the current LT-Debt-to-Total-Asset is 0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Catheter Precision (FRA:4RM) Overvalued in 2026?

Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued. The current stock price of €100.89 is trading 53.8% below its estimated GF Value™ of €218.38.

Key valuation signals for FRA:4RM:

LT-Debt-to-Total-Asset: 0.11
GF Value™: €218.38 vs. price of €100.89 (53.8% below fair value)
GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the FRA:4RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Catheter Precision Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies ALURD BJDX AMIX LUDG FEED BTCY VYCO AEMD USAQ ADMT ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges VTAK:USA

Address 1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708

Website https://www.catheterprecision.com

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

23GF Score

Get the complete analysis for FRA:4RM

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€100.89

Price

€218.38

GF Value

View FRA:4RM Analysis

See LT-Debt-to-Total-Asset data for all stocks →